Pharmaceutical composition containing as active ingredient compound conjugated to g4 structures of coronaviruses for prevention or treatment of coronavirus infectious diseases

Abstract

The present invention relates to a composition for preventing or treating coronavirus infectious diseases, comprising a compound that binds to G4 structures of coronaviruses. Since the compound according to the present invention can bind to G4 structures of coronaviruses to stabilize the G4 structures, reduce the protein expression of coronaviruses, and effectively inhibit cell infection by viruses, the compound is expected to be used in the prevention or treatment of coronavirus infectious diseases.

Dependencies are inferred from the claim text.